Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Compare the pharmacokinetic (PK) of High Metals abatacept relative to Low Metals abatacept following a single intravenous infusion of 750 mg in healthy subjects.
Age
18–55
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy subjects as determined by no clinically significant deviation from normal in medical history, physical examination, ECGs, and clinical laboratory determinations
Body weight will be between 60 and 100 kg, inclusive
You may not be if
Any significant acute or chronic medical illness
Any major surgery within 4 weeks of study drug administration
Smoking more than 10 cigarettes per day
Recent (within 6 months of study drug administration) drug or alcohol abuse
Positive blood screen for hepatitis C antibody, hepatitis B surface antigen, or HIV-1, -2 antibody
History of any significant drug allergy or asthma
Women who are pregnant or breastfeeding and/or unwilling or unable to use an acceptable method to avoid pregnancy for the entire study period
